Old Web
English
Sign In
Acemap
>
Paper
>
MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
2021
Q. Zhou
Yi-Long Wu
J Chang
Hong Wang
Yun Fan
Jiuran Zhao
G. Wu
Y. Sun
M. Sun
Xizhang Wang
H. Shi
W Nian
K. Wang
X. Zheng
L. Qu
S. Yao
Z. Shen
P. Li
Jin-Ji Yang
Keywords:
Medicine
Cancer research
RET Fusion
Lung cancer
non small cell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]